Opening book details…
Can I read Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development) on EtoBox?
Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development) by Doriano Fabbro (Editor), Frank McCormick (Editor) is a medicine available to read on EtoBox.
What is Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development) about?
Leading researchers, from the Novartis group that pioneered Gleevec/GlivecTM and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of resistance, etc.) aimed at generating PTK inhibitors for the treatment of various diseases, including cancer. Highlights include a discussion of the rationale and the progress made towards generating "selective" low molecular-weight kinase inhibitors;
Who reads Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)?
It is typically read by working professionals who need an authoritative practice reference.
Common subject areas: medicine, law, business, engineering.
- Author
- Doriano Fabbro (Editor), Frank McCormick (Editor)
- Publisher
- Humana Press
- Published
- 2005
- Language
- EN
- ISBN
- 9781588293848
- Category
- medicine
- Subjects
- Science, Chemistry, Medical
- Updated
- 2026-03-25
Other editions & translations
More by Doriano Fabbro (Editor), Frank McCormick (Editor)
Browse all works by Doriano Fabbro (Editor), Frank McCormick (Editor)
Similar books
- Cell Cycle Inhibitors In Cancer Therapy: Current Strategies (cancer Drug Discovery And Development) — Giulia De Falco PhD, Catherine Soprano (auth.), Antonio Giordano MD, PhD, Kenneth J. (2003)
- Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) — Barry Greene, Michael Kauffman (auth.), Julian Adams PhD (2004)
- STAT Inhibitors in Cancer (Cancer Drug Discovery and Development) — Alister C. Ward (2016)
- Antifolate Drugs In Cancer Therapy (cancer Drug Discovery And Development) — Robert C. Jackson (auth.), Ann L. Jackman (1999)
- Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) — Saïd M. Sebti; Andrew D. Hamilton (2001)
- PARP Inhibitors for Cancer Therapy (Cancer Drug Discovery and Development) — Nicola J. Curtin, Ricky A. Sharma (2015)
